TSPOAP1 and acute myeloid leukemia: Based on the heat map analysis of diseases and functions, TSPOAP1 can be explored as a potential drug target for phosphatidylglycerol-regulated functions, Alzheimer's disease, progressive neurological disorder, adhesion of acute myeloid leukemia blast cells, and adhesion of human coronary artery endothelial cells (HCAEC) (Figure 2E and Supplementary Figures S9–S10).